コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 osa, Haemophilus, Aspergillus fumigatus, and nontuberculous mycobacteria.
2 ons with intracellular pathogens, especially nontuberculous mycobacteria.
3 MGIT cultures included both tuberculous and nontuberculous mycobacteria.
4 evalence population, including the impact of nontuberculous mycobacteria.
5 concern about public health issues regarding nontuberculous mycobacteria.
6 dentification of MTC and clinically relevant nontuberculous mycobacteria.
7 isseminated infections with environmental or nontuberculous mycobacteria.
8 greater percentage had cultures positive for nontuberculous mycobacteria.
9 with DNA from Mycobacterium avium and other nontuberculous mycobacteria.
10 the culture filtrates of M. avium and other nontuberculous mycobacteria.
11 16 were MTBC (from 12 patients), and 41 were nontuberculous mycobacteria.
12 CG or from sensitization with environmental, nontuberculous mycobacteria.
13 imens of M. tuberculosis and 29 specimens of nontuberculous mycobacteria.
14 that this array can identify the species of nontuberculous Mycobacteria.
15 nfer susceptibility to severe infection with nontuberculous mycobacteria.
16 e 1,353 isolates recovered, 1,110 (82%) were nontuberculous mycobacteria, 145 (11%) were aerobic acti
17 after 6 weeks of incubation included 65 (5%) nontuberculous mycobacteria, 4 (0.3%) aerobic actinomyce
18 onella and other gram-negative bacteria, and nontuberculous mycobacteria, although fungi and viruses
19 s assessed by DNA extraction from species of nontuberculous mycobacteria and amplification using the
20 test reactions associated with reactivity to nontuberculous mycobacteria and bacille Calmette-Guerin
22 acterium tuberculosis complex (MTBC), 6 grew nontuberculous mycobacteria, and 2 (from two patients di
23 vaccination, discriminated responses due to nontuberculous mycobacteria, and avoided variability and
24 A extracted from Mycobacterium tuberculosis, nontuberculous mycobacteria, and nonmycobacterial specie
25 (IFN)-gamma autoantibodies and disseminated nontuberculous mycobacteria; anti-granulocyte macrophage
27 nosa, Vibrio cholerae and certain species of nontuberculous mycobacteria are examples of human pathog
30 abscessus, a species of multidrug-resistant nontuberculous mycobacteria, are emerging as an importan
33 false positive MTD results in patients with nontuberculous mycobacteria, for a specificity in this p
34 al nervous system (CNS) infections caused by nontuberculous mycobacteria have been described previous
35 as capable of identifying several species of nontuberculous mycobacteria in addition to identifying M
36 Nonsequencing methods for identification of nontuberculous mycobacteria (including those of the MAC)
39 oid Pseudomonas aeruginosa (n = 12; 15%) and nontuberculous mycobacteria (n = 8; 10%) were present in
40 as developed for efficient identification of nontuberculous mycobacteria (NTM) and their environmenta
46 idrug-resistant strains, and some species of nontuberculous mycobacteria (NTM) compared with that of
48 ex (MTBC) and 1.00, 0.97, 0.75, and 1.00 for nontuberculous mycobacteria (NTM) detection, respectivel
49 uginosa and allow the successful recovery of nontuberculous mycobacteria (NTM) from cystic fibrosis (
50 us (AFB) culture method for the isolation of nontuberculous mycobacteria (NTM) from patients with CF.
53 outbreaks and pseudo-outbreaks caused by the nontuberculous mycobacteria (NTM) have been recognized f
56 entiation of Mycobacterium tuberculosis from nontuberculous mycobacteria (NTM) is of primary importan
57 erium abscessus complex (MABSC) is a form of Nontuberculous mycobacteria (NTM) of special, internatio
58 rium tuberculosis complex (MTC) strains from nontuberculous Mycobacteria (NTM) strains by targeting t
59 dence of pulmonary infection via aerosolized nontuberculous mycobacteria (NTM), it is important to ch
60 Mycobacterium tuberculosis complex (MTC) and nontuberculous mycobacteria (NTM), using surface-enhance
64 ern corresponded to sequence conservation in nontuberculous mycobacteria (NTMs), suggesting environme
65 e-positive by Xpert MTB/RIF in patients with nontuberculous mycobacteria, old PTB scar, and immune re
67 features of patients infected with pulmonary nontuberculous mycobacteria (PNTM) are well described, b
69 ls have more cases of clinically significant nontuberculous mycobacteria than tuberculosis, the manag
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。